Cargando…
An analysis of blood pressure screening of 21 112 participants in Armenia: May Measurement Month 2018
Elevated blood pressure (BP) is a growing burden worldwide and is the leading cause of mortality and disability-adjusted life years all over the world. May Measurement Month (MMM) is a global initiative aimed to raise awareness of high BP and to act as a temporary solution to the lack of screening p...
Autores principales: | Zelveian, Parounak, Avagyan, Avag, Minasyan, Arsen, Hayrumyan, Samvel, Gourgenyan, Svetlana, Hakobyan, Zoya, Kzhdryan, Hovhannes, Hakobjanyan, Vahan, Ustyan, Tsiala, Gharibyan, Heghine, Melkonyan, Arevik, Aroyan, Siranush, Vatinyan, Susanna, Beaney, Thomas, Ster, Anca Chis, Poulter, Neil R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455293/ https://www.ncbi.nlm.nih.gov/pubmed/32884458 http://dx.doi.org/10.1093/eurheartj/suaa017 |
Ejemplares similares
-
May Measurement Month 2019: an analysis of blood pressure screening
results from Armenia
por: Zelveian, Parounak, et al.
Publicado: (2021) -
May Measurement Month 2017: an analysis of blood pressure screening results in Armenia—Europe
por: Zelveian, Parounak, et al.
Publicado: (2019) -
Accuracy of the Withings BPM Connect Device for Self-Blood Pressure Measurements in General Population – Validation According to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard
por: Topouchian, Jirar, et al.
Publicado: (2022) -
Clinical Accuracy of the Withings BPM Connect for Self-Blood Pressure Measurements in Pregnancy and Pre-Eclampsia: Validation According to the Association for the Advancement of Medical Instrumentation/European Society of Hypertension/International Organization for Standardization Universal Standard
por: Zelveian, Parounak, et al.
Publicado: (2022) -
Validation of BP devices QardioArm(®) in the general population and Omron M6 Comfort(® )in type II diabetic patients according to the European Society of Hypertension International Protocol (ESH-IP)
por: Chahine, Mirna N, et al.
Publicado: (2017)